First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases

NCT05599945 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Hepatic Steatosis

Interventions

DRUG: NNC0581-0001
DRUG: Placebo (NNC0581-0001)

Sponsor

Novo Nordisk A/S